600 patients66,869 observations120 daysLIVE

Patient P-01597

Synthetic patientNBL-101 · Day 120 · 35–44 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Unstable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
89%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 47 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 57 GI-04 recommendedGI Support Protocol GI-04
  4. Day 58 Patient acceptedStarted GI-04 in the companion
  5. Day 66 No meaningful changeGI Support Protocol GI-04

What changed?

Trajectory began diverging from predicted response on Day 47.

Primary contributors, last 14 days
  • Treatment adherence+9
  • Inflammatory activity+5
  • Toxicity+3

What helped?

  • GI Support Protocol GI-04Day 57
    Result: no meaningful change
LIFE OS recommendation
Dietary Support Protocol NP-02
59%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
79.2/100
improving · -3.8 vs previous 14 d
Toxicity
Blood
61.3/100
worsening · +8.9 vs previous 14 d
Sleep quality
Wearable
3.7/100
improving · +5.2 vs previous 14 d
Energy level
Daily log
0.4/10
improving · +0.1 vs previous 14 d
Stress level
Daily log
8.7/10
stable · +0.2 vs previous 14 d
Steps
Wearable
340
stable · +14 vs previous 14 d
Adherence
Companion
46.7 %
stable · +0.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 23 from the failing basin, 86 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 71%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 71%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 71%
Would not help
  • GI-04 GI Support Protocol
    already tried, no meaningful change
  • Keep fat low
    GI +4.2 next day on high-intake days · n 22
  • Keep simple carbs low
    GI +2.8 next day on high-intake days · n 22
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +4.2detractor · 95%
  • Simple carbohydrates
    +2.8detractor · 85%
  • Insoluble fibre
    +1.1no signal · 33%
  • Spicy / capsaicin
    -0.9no signal · 24%
  • Alcohol
    -0.8no signal · 25%
  • Histamine load
    -0.6no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 65
    • WearableResting HR 74 bpm
    • Wearable340 steps/day
    • WearableShort sleep window
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 79 and rising
    • WearableSleep 5.2 h, below personal baseline
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 40/100
    • Daily logFibre intake low in recent food logs
  • Inflammatory signalling 40
    • BloodInflammatory load index 71
    • WearableHRV 15 ms, trending down
  • Drug metabolism and exposure 20
    • BloodToxicity index 61
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.7 · butyrate capacity 40/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
15 ms
Sleep
5.6 h
Steps
477
Resting HR
73 bpm
Daily log: GI score 79, nutritional resilience 30, adherence 47.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0185448%S14ME-01improved46
P-0161543%S14ME-01improved48
P-0165642%S14ME-01improved41
P-0172042%S14NP-02improved47
P-0181042%S05NP-02improved43
P-0172841%S14SC-12improved41
P-0173641%S03ME-01improved46
P-0173941%S14ME-01improved44
P-0149240%S15ME-01improved44
P-0160540%S14ME-01improved41
P-0187240%S14NP-02improved47
P-0189740%S14ME-01improved43